Archive · 19 Aug 2026
Broker Retains Sell on Praj Industries Amid Near-Term Profitability Pressure
Praj Industries reported better sales in the first quarter of FY27.
Revenue grew to ₹720 crore, helped by its bioenergy and HiPurity businesses.
Some other parts of the business remained weak because projects were delayed and customers faced funding problems.
The company received more new orders, including a large ethanol order from Brazil.
However, these newer opportunities are still too small to fully replace weakness in the core business.
Profit increased sharply, but this was helped by other income and lower interest costs.
The broker believes profits may remain under pressure while the company invests in new businesses.
Because recovery is difficult to predict, the broker kept a Sell recommendation and set a ₹285 target price.
Praj Industries’ Q1 FY27 consolidated revenue rose 11.8% year on year to ₹720 crore.
Bioenergy and HiPurity supported growth, while engineering and domestic first-generation ethanol activity remained subdued.
Order intake increased 25.8% to ₹1,000 crore, with exports contributing 43% and Brazil providing an 800-klpd corn-to-ethanol order.
PAT rose 117.3% to ₹11.6 crore, helped by higher other income and lower interest costs despite weak operating leverage.
The broker retained its Sell rating with a ₹285 target price versus a CMP of ₹340.70, citing limited near-term earnings visibility.
- Who
- Praj Industries and the broker covering its shares.
- What
- Praj Industries reported Q1 FY27 results, including higher revenue, order intake and profit, while the broker retained a Sell recommendation.
- When
- The report was published on August 19, 2026, covering Q1 FY27.
- Where
- Growth was driven by international markets, including a corn-to-ethanol order from Brazil; the report also discusses exports to the African Union, European Union and the Americas.
- Why
- The broker expects near-term profitability to remain pressured by project delays, subdued operating leverage, continued GenX investment and limited margin visibility.
Broker’s concerns
Company growth initiatives
Near-term earnings
Broker’s concerns
The broker expects profitability to remain under pressure because of project delays, weak operating leverage and ongoing GenX investments.
Company growth initiatives
The company is expanding into newer businesses, while bioenergy, HiPurity and international markets are already supporting revenue and orders.
Order momentum
Broker’s concerns
The broker notes that newer opportunities are still nascent and have not meaningfully offset weakness in the core business.
Company growth initiatives
Order intake rebounded to ₹1,000 crore, driven by international markets and newer applications, including a major Brazil order.
Market recovery visibility
Broker’s concerns
The absence of management margin guidance suggests limited visibility into the pace of recovery, according to the broker.
Company growth initiatives
The international order pipeline and increased export contribution indicate potential areas for future growth, although the article does not quantify their eventual earnings impact.
- Current market price
- ₹340.70
- Broker target price
- ₹285
- Q1 FY27 revenue
- ₹720 crore, up 11.8% year on year
- Q1 FY27 order intake
- ₹1,000 crore, up 25.8% year on year
- Q1 FY27 PAT
- ₹11.6 crore, up 117.3% year on year
- Export share of order intake
- 43% in Q1 FY27
- Major new order
- An 800-klpd corn-to-ethanol order from Brazil